Antifungals in the treatment of allergic bronchopulmonary aspergillosis

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 6, 1999, Pages 511-517

  Leon, Eddie E ^a   Craig, Timothy J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ASTEMIZOLE; CISAPRIDE; CLOTRIMAZOLE; CYCLOSPORIN; DIAZEPAM; DIGOXIN; HAMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NATAMYCIN; NYSTATIN; PHENOBARBITAL; PHENYTOIN; POTASSIUM IODIDE; PREDNISONE; QUINIDINE; RIFABUTIN; RIFAMPICIN; TACROLIMUS; TERFENADINE; UNINDEXED DRUG; VINCA ALKALOID;

ALLERGY; ANAPHYLAXIS; CLINICAL FEATURE; DISEASE COURSE; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG POTENTIATION; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; REVIEW; STEROID THERAPY;

EID: 0033062690     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63157-2     Document Type: Review

References (36)

1. Miller PW, Hamosh A, Macek Jr M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59: 45-51.
2. Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983;143:1553-1557.
3. Schwartz HJ. Problems with skin testing in patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1995;75:533-535.
4. Hemmann S, Nikolaizik WH, Schoni MH, et al. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998;28:1155-1160.
5. Banerjee B, Kurup VP, Greenberger PA, et al. Purification of a major allergen, Asp f2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of aspergillus fumigatus. J Allergy Clin Immunol 1997;99: 821-827.
6. Little SA, Warner JO. Improved diagnosis of allergic bronchopulmonary aspergillosis with gp66 (formerly antigen 7) of Aspergillus fumigatus for specific IgE detection. J Allergy Clin Immunol 1996;98:55-63.
7. Patterson R, Greenberger PA, Halwig M, et al. Allergic bronchopulmonary aspergillosis - national history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916-918.
8. Nichols D, Dopico GA, Braun S, et al. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 1979;67: 631-637.
9. Rosenberg M, Patterson R, Roberts M, Wang J. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978;64:599-605.
10. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis -model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 1987;91:165S-171S.
11. Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 1981; 68:98-102.
12. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: a review and report of eight new cases. Thorax 1952;7:317-333.
13. Stark JE. Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin. Dis Chest 1967;51:96-99.
14. Henderson AH, Pearson EG. Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin. Thorax 1968;23:519-523.
15. Sandhu RS, Mishra SK, Randhawa HS, Parkash D. Allergic bronchopulmonary aspergillosis in India. Scand J Respir Dis 1972;53:289-301.
16. Currie DC, Lueck C, Milburn HJ, et al. Controlled trial of natamycin in the treatment of allergic bronchpulmonary aspergillosis. Thorax 1990;45: 447-450.
17. Slavin RG, Stanczyk DJ, Lonigro AJ, Broun GO. Allergic bronchopulmonary aspergillosis - A North American rarity. Am J Med 1969;47:306-313.
18. Slavin RG, Laird TS, Cherry JD. Allergic bronchopulmonary aspergillosis in a child. J Pediatr 1970;76:416-421.
19. Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987;42: 26-31.
20. Fournier EC. Trial of ketoconazole in allergic bronchopulmonary aspergillosis. Thorax 1987;42:831.
21. Radha TG, Viswanathan R. Allergic bronchopulmonary aspergillosis. Respiration 1978;36:104-111.
22. Earis JE, Bernstein AA. Mucoid impaction of the bronchi apparently responding to antifungal therapy. Chest 1979;76:116.
23. Crompton GK, Milne LJR. Treatment of bronchopulmonary aspergillosis with clotrimazole. Br J Dis Chest 1973;67:301-307.
24. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100: 813-819.
25. Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 1995;107:883.
26. Mannes GPM, Van Der Heide S, Van Aalderen WMC, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet. 1993;341:492.
27. Pacheco A, Martin JA, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 1993;103:980-981.
28. Lebeau B, Pelloux H, Pinel C, et al. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses 1994;37:171-179.
29. De Beule K, De Doncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 1988;31:476-485.
30. Nikaido Y, Nagata N, Yamamoto T, et al. A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole. Respir Med 1998; 92:118-124.
31. Matsuzaki Y, Jimi T, Tao Y, et al., Allergic bronchopulmonary aspergillosis successfully treated with itraconazole. Japanese J Thoracic Dis 1997; 35:352-356.
32. Tucker RM, Haq Y, Denning DW, Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 1990;26:561-566.
33. Watkins DN, Badcock NR, Thompson PJ. Itraconazole concentrations in airway fluid and tissue. Br J Clin Pharmac 1992;33:206-207.
34. Denning DW, Radford SA, Oakley KL, et al. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997;40:401-414.
35. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41: 1364-1368.
36. Murphy JL. Monthly Prescribing Reference. January 1999. New York, NY: Prescribing Reference, Inc, 1999:173.